SCHEMBL2160839

SCHEMBL2160839

CC1SCCCSC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5068767 0.87
SCHEMBL10301 0.80
SCHEMBL12548834 0.72
SCHEMBL8223833 0.72
SCHEMBL1869574 0.70
SCHEMBL20411945 0.70
SCHEMBL20411931 0.70
SCHEMBL11381693 0.70
SCHEMBL14010699 0.68
SCHEMBL14275697 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985771-B2 Skin disorders; aging resistance MONSANTO TECHNOLOGY LLC (US) 2011-07-26 US disclosed
EP-1660080-A1 FURANONE DERIVATIVES Galileo Pharmaceuticals, Inc. (US) 2006-05-31 EP disclosed
EP-1478634-A4 FURANONE DERIVATIVES GALILEO PHARMACEUTICALS INC (US) 2006-02-01 EP disclosed
WO-2005016340-A1 FURANONE DERIVATIVES GALILEO PHARMACEUTICALS, INC. (US) 2005-02-24 WO disclosed
EP-1478634-A1 FURANONE DERIVATIVES Galileo Pharmaceuticals, Inc. (US) 2004-11-24 EP disclosed
US-20040029812-A1 Furanone derivatives MONSANTO TECHNOLOGY LLC 2004-02-12 US disclosed
US-6667330-B2 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions GALILEO PHARMACEUTICALS, INC. 2003-12-23 US disclosed
US-20030176361-A1 Furanone derivatives MONSANTO TECHNOLOGY LLC 2003-09-18 US disclosed
WO-2003064403-A1 FURANONE DERIVATIVES GALILEO LABORATORIES, INC. (US) 2003-08-07 WO disclosed